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Abstract
Trypanosomatids’ amino acid permeases are key proteins in parasite metabolism since they participate in the adaptation of
parasites to different environments. Here, we report that TcAAP3, a member of a Trypanosoma cruzi multigene family of
permeases, is a bona fide arginine transporter. Most higher eukaryotic cells incorporate cationic amino acids through a
single transporter. In contrast, T. cruzi can recognize and transport cationic amino acids by mono-specific permeases since a
100-fold molar excess of lysine could not affect the arginine transport in parasites that over-express the arginine permease
(TcAAP3 epimastigotes). In order to test if the permease activity regulates downstream processes of the arginine
metabolism, the expression of the single T. cruzi enzyme that uses arginine as substrate, arginine kinase, was evaluated in
TcAAP3 epimastigotes. In this parasite model, intracellular arginine concentration increases 4-folds and ATP level remains
constant until cultures reach the stationary phase of growth, with decreases of about 6-folds in respect to the controls.
Interestingly, Western Blot analysis demonstrated that arginine kinase is significantly down-regulated during the stationary
phase of growth in TcAAP3 epimastigotes. This decrease could represent a compensatory mechanism for the increase in
ATP consumption as a consequence of the displacement of the reaction equilibrium of arginine kinase, when the
intracellular arginine concentration augments and the glucose from the medium is exhausted. Using immunofluorescence
techniques we also determined that TcAAP3 and the specific lysine transporter TcAAP7 co-localize in a specialized region of
the plasma membrane named flagellar pocket, staining a single locus close to the flagellar pocket collar. Taken together
these data suggest that arginine transport is closely related to arginine metabolism and cell energy balance. The clinical
relevance of studying trypanosomatids’ permeases relies on the possibility of using these molecules as a route of entry of
therapeutic drugs.
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Introduction
Trypanosoma cruzi is the causative agent of Chagas ‘disease, a
zoonosis affecting approximately 18 million people in the
Americas [1]. This protozoan parasite has a complex life cycle,
involving morphological changes and a wide variety of environ-
ments with different composition, mainly the insect vector gut,
mammalian blood and mammalian host cell cytoplasm. In
consequence, the parasite survival mainly depends on their
adaptive ability and metabolic plasticity. A critical aspect to
achieve these adaptations is the parasite potential to take
advantage of the available metabolites in the different extracellular
milieus using a large repertoire of nutrient permeases. One of the
major amino acid transporter families is the ‘‘Amino Acid/Auxin
Permease Family’’ (AAAP; TC 2.A.18) which is largely represent-
ed in plants [2]. In T. cruzi, many members of this family were first
identified by our group [3] and then confirmed by the TriTryps
genome project [4]. This T. cruzi family, called TcAAAP, has more
than 30 genes coding for proteins with lengths of 400–500 amino
acids and 10–12 predicted transmembrane a-helical spanners.
One interesting feature of this permease family is the absence of
similar sequences in mammalian genomes; however, the presence
of unidentified orthologs could not be discarded [5]. T. cruzi
arginine transport systems have been largely studied during the
last decade [6]; even so, the first evidence of the molecular
determinants of this process was recently reported. TcAAP3
(formerly TcAAAP411), a member of the TcAAAP family, has an
arginine transport activity in a yeast model [7]. A similar arginine
transporter (LdAAP3) was also identified in the protozoan parasite
Leishmania donovani [8]. LdAAP3 regulation mainly depends on
the availability of the extracellular substrate since amino acid
starvation produces an increase in arginine transport and LdAAP3
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protein abundance [9]. Interestingly, a similar mechanism of
regulation was described for arginine and other T. cruzi amino
acids transport systems [10], supporting the hypothesis that most
of the previously characterized transport systems in trypanosoma-
tids involve members of the TcAAAP family. On the other hand,
lysine transporters from this family were also identified and
characterized in Trypanosoma spp. and Leishmania spp. [11]. In
higher eukaryotes most of cationic amino acids transporters
incorporate arginine and lysine by a single permease [12,13,14].
On the contrary, parasite permeases translocate cationic amino
acids by different mono-specific transporters [6,11]. Taken
together, these differences suggest that amino acid transporters
may provide multiple and unexplored targets and gateways for
therapeutic drugs.
In this work we validated the functionality of TcAAP3 in vivo by
homologous over-expression in T. cruzi epimastigotes. We also
studied the TcAAP3 specific localization in the parasite surface
and its contribution on the regulation of arginine metabolism and
cell energy balance.
Materials and Methods
Cell cultures
Epimastigotes of the MJ-Levin strain were cultured at 28uC in
plastic flasks (25 cm2), containing 5 mL of LIT medium (started
with 106 cells per milliliter) supplemented with 10% fetal calf
serum, 100 U/mL penicillin, and 100 mg/mL streptomycin [15].
The parasites were subcultured with passages each 7 days. Cells
were counted using a hemocytometer. The MJ-Levin T. cruzi
strain was recently typified according to the mini-exon sequences
from twenty independent clones (Schijman et al., personal
communication). Based on these results the strain has been included
in the typing unit 1 [16].
Arginine and lysine transport assays
Aliquots of epimastigote cultures (36107 parasites) were
centrifuged at 8,0006g for 30 s, and washed once with
phosphate-buffered saline (PBS). Cells were resuspended in
0.1 mL PBS and then added 0.1 mL of the transport mixture
containing 100 mM L-(3H) arginine or lysine (PerkinElmer’s
NENH Radiochemicals; 0.4 mCi). Following incubation for
10 min at 28uC, reaction was stopped by adding 1 mL of ice-
cold PBS. Cells were centrifuged as indicated above, and washed
twice with ice-cold PBS. Cell pellets were resuspended in 0.2 mL
of water and counted for radioactivity in UltimaGold XR liquid
scintillation cocktail (Packard Instrument Co., Meridien CT, USA)
[6]. Assays were run at least by triplicate. Cell viability was
assessed by direct microscopic examination. Non-specific uptake
and carry over were measured in transport mixture containing
10 mM L-arginine (100-fold molar excess), or in standard
transport mixture incubated at 4uC.
Plasmid constructions and parasite tranfection
TcAAP3, TcBilbo1 and TcAAP7 genes (GeneDB: Tc00.
1047053511411.30, Tc00.1047053511127.20, and Tc00.1047053
511127.20, respectively) were amplified using genomic T. cruzi
DNA as template and the following primers: TcAAP3F 59
ATGGGCACCGAGAGTGGCAA 39; TcAAP3R 59 TTACC-
GAACCACACCATACA 39; TcBilbo1F 59 ATGTTGGTCAT-
TAATGTAGCCGCTG 39; TcBilbo1R 59 GGATCCGGAT-
CGTCCTCCCTGCAGCT 39; TcAAP7F 59 ATGTATGACA-
ACGTCAATGAGG 39; and TcAAP7R 59 GTCGACTCAGC-
CATGGGCTTCG 39. Amplification products were cloned into a
modified pTREX expression plasmid called pTREXL [17];
(Bouvier et al. unpublished observations) or fused to mCherry
(mCherry::TcAAP3; the name corresponds to the order in which
the genes were fused) and eGFP (TcBilbo1::eGFP; eGFP::T-
cAAP7) genes present in the pTREXL plasmids. Constructions
were transfected into T. cruzi epimastigotes as follows. 108 parasites
grown at 28uC in LIT medium were harvested by centrifugation,
washed with PBS, and resuspended in 0.35 mL of electroporation
buffer (PBS containing 0.5 mM MgCl2 and 0.1 mM CaCl2). This
cell suspension was mixed with 50 mg of plasmid DNA in 0.2 cm
gap cuvettes (Bio-Rad Laboratories). The parasites were electro-
porated using a single pulse of (400 V, 500 mF) with a time
constant of about 5 ms.
Fluorescence Microscopy
Epimastigote samples from the days 1–7 after transfection, were
washed twice with PBS. After letting the cells settle for 30 min at
room temperature onto poly-L-lysine coated coverslips, parasites
were fixed at room temperature for 20 min with 4% formaldehyde
in PBS, followed by a cold methanol treatment for 5 min. Slides
were mounted using Vectashield with DAPI (Vector Laboratories).
Cells were observed in an Olympus BX60 fluorescence micro-
scope. Images were recorded with an Olympus XM10 camera.
Amino acid and ATP determinations
Epimastigote cells were counted using a hemocytometric
chamber, harvested by centrifugation at 1,5006g for 10 min
and washed three times with PBS. Cell pellets were then
resuspended in MilliQ water and lysed by 5 cycles of freezing
and thawing. Samples (0.2 mL) were centrifugated and the soluble
fraction was mixed with (5 mL) b-mercaptoethanol and allowed to
stand for 5 minutes at room temperature followed by precipitation
with ice-cold methanol (800 mL) while vortexing. Tubes were
allowed to stand for 15 minutes in ice before centrifuging and the
supernatant was collected. Efficiency of protein precipitation step
was assessed by Bradford’s method. The protein free supernatants
obtained from 56108 parasites were dried in a rotary evaporator,
resuspended in 20 mL of milliQ water and processed immediately
for assaying total amino acids by HPLC analysis or stored at
280uC until further analysis. Amino acids were derivatizated and
analyzed using the AccQ. Tag Amino Acid Analysis Method
(Waters) according to the manufacturer instructions. ATP
determinations were performed using the ‘‘ATP Bioluminiscence
Assay Kit HS II’’ (Roche) according to the manufacturer
instructions. Glucose determinations were performed using the
‘‘Enzymatic Glycemia Kit’’ (Biosystems) according to the manu-
facturer instructions. Assays were run at least by triplicate.
Bioinformatics
Sequences from the ‘‘Tritryps’’ genome projects were obtained
at GeneDB (http://www.genedb.org/) and TcruziDB (http://
tcruzidb.org/). Assembly and analysis of the DNA sequence data
were carried out using the software package Vector NTI v. 10.3.0
(Invitrogen) and the online version of BLAST at the NCBI
(http://www.ncbi.nlm.nih.gov/BLAST/). Local or online soft-
ware were used under default parameters. Reference metabolic
pathways were obtained from the Kyoto Encyclopedia of Genes
and Genomes - KEGG (www.genome.jp/kegg/).
Results and Discussion
TcAAP3 encodes an arginine transporter
To study whether TcAAP3 is a bona fide arginine permease in T.
cruzi, the full-length TcAAP3 and the eGFP genes were cloned
in the expression vector pTREXL and epimastigote cells were
T. cruzi Arginine Transporter
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transfected with the different plasmid constructions. After the
selection period, pTREXL-TcAAP3 transfected parasites
(TcAAP3 epimastigotes) showed an arginine transport rate of
about 2.5-folds greater than pTREXL-eGFP controls (Figure 1,
image 1). The increase in the arginine transport rate seems not to
be well tolerated by T. cruzi epimastigotes, in contrast to the
previously studied lysine transporter TcAAP7. While the transport
of lysine has been increased in 50-folds by over-expression of
TcAAP7 [11], in the case of arginine transport we failed to
obtained cell clones exceeding about 2.5-folds the control rate
using exactly the same approach. This phenomenon could be
related to alterations in the T. cruzi arginine metabolism, in
contrast to the lysine one, which is probably limited to
osmoregulation and protein synthesis [11].
TcAAP3 epimastigotes did not present morphological differ-
ences respect to the controls. However, transfected parasites
showed impaired growth kinetics, reaching a cell density of
7.56107 (61.26107) cells per mL, and the GFP controls 12.36107
(61.26107) cells per mL at the late stationary phase of culture.
This growth phenotype could be due to the toxicity of the over-
expressed membrane protein per se or to the metabolic effects as a
consequence of increased arginine concentrations, as explained
below.
TcAAP3 is highly specific for arginine
Mammalian cells transporters incorporate arginine and lysine
together through a single cation amino acid transporter; however,
previous studies from our group demonstrated that the T. cruzi and
Leishmania lysine permeases (AAP7) are mono-specific [11]. To test
if TcAAP3 is also a mono-specific permease, arginine and lysine
transport assays were performed using TcAAP3 epimastigotes and
GFP transfected parasites. As Figure 1 (image 1) shows, TcAAP3
epimastigotes presented an increase only in arginine, but not in
lysine transport rate compared to the pTREXL-GFP controls.
Additionally, when arginine transport assays were performed in
the presence of a 100-folds molar excess of lysine, the measured
rates remain unaltered. As expected, only an excess of arginine
produced an inhibition of the (3H)-L-arginine intake by isotopic
dilution. These results confirm that TcAAP3 is, unlike mammalian
transporters, a mono-specific arginine permease.
In order to predict the putative molecular determinants of the
substrate specificity, a comparative bioinformatic analysis was
performed using different approaches. The amino acid sequences of
all members of the TcAAAP family present a highly variable N-
terminal domain (about 90 amino acids, 5% of consensus) which
constitutes a candidate to be the determinant of the permeases
specificity [7]. Recently it was reported that these variable regions
are phosphorilated by unidentified kinases that may represent a
regulation mechanism of permeases activity [18]. In contrast, the
central and C-terminal domains have .70% of consensus amino
acid positions. Despite the variable regions of T. cruzi and Leishmania
orthologs do not share any clearly similar motif, a region of
negatively charged amino acids was found between the 6th and the
7th predicted transmembrane spans, corresponding to TcAAP3
residues 291–305 (Figure 1, image 2). This charged region, also
present in TcAAP7 and in both TcAAP3 and TcAAP7 Leishmania
orthologs, can be the cationic amino acids recognition motif.
Over-expression of TcAAP3 increases the intracellular
arginine concentration
In order to test if the elevated rates of arginine transport,
derived from TcAAP3 over-expression, produce an increase in the
intracellular arginine pools, amino acid concentrations were
determined by derivatization and further resolution by reversed-
phase chromatography. Control parasites transfected with an
empty plasmid presented an arginine concentration of 0.46 mM
and TcAAP3 epimastigotes 1.73 mM, representing an increase
in intracellular arginine concentration of about 3.8-fold. No
differences were observed in lysine concentration between both
transfected parasite groups. These results not only reinforce the
data about the mono-specificity of the transporter, but also suggest
that if exist any compensatory mechanism that maintain the
physiological levels of arginine, it is inactive or insufficient to
restore the equilibrium in this parasite model.
Arginine kinase is the only predicted arginine consuming
enzyme in Trypanosoma cruzi
Arginine metabolism has been largely studied in trypanosomes
but there are still many unresolved issues. T. cruzi is unable to
synthesize arginine; therefore the amino acid is obtained from the
host through different transport systems [19]. In trypanosomatids,
most of the well-studied enzymatic reactions involving L-arginine
have been related to the ornithine-arginine pathway. T. cruzi lack
ornithine decarboxylase, arginine decarboxylase and arginase,
indicating that it is unable to neither synthesize diamines from
either L-arginine or L-ornithine, nor excrete the nitrogenous waste
by the urea cycle [19]. To identify genes coding for arginine
metabolizing enzymes, a carefully bioinformatic approach by data
mining was performed. None of the genes coding for enzymes of
the urea cycle, nopaline or octopine dehydrogenases, nitric oxide
synthases, arginine monooxygenases, arginine deiminase, glycine
amidotransferase, arginine succinyltransferase, arginine/ornithine
decarboxylase and arginine transaminases, have been identified
(Figure 2, image 1). These data suggest that T. cruzi would be
Figure 1. Substrate specificity of TcAAP3. 1) Radiolabeled L-
arginine (100 mM, black) or L-lysine (100 mM, grey) uptake was
measured in TcAAP3 over-expressing parasites (TcAAP3), GFP controls
(GFP), and in the presence of 100-fold molar excess of lysine (Lys) or
arginine (Arg). Uptake rates of arginine and lysine are expressed as a
percentage of the GFP controls and correspond to 93 and 21 pmol/min
per 108 cells, respectively. 2) Schematic representation of the arginine
permease (TcAAP3) and the previously characterized lysine permease
(TcAAP7). N-terminal red diamonds represent the variable region of the
TcAAAP permeases, numbered yellow diamonds represents the
transmembrane spans, and blue boxes are the putative cationic amino
acids binding motifs.
doi:10.1371/journal.pone.0032760.g001
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unable to use arginine as an alternative carbon source like proline
and other amino acids. To preliminary test this hypothesis
different epimastigotes samples were incubated in PBS, or PBS
supplemented with 10 mM glucose, proline, glutamate or
arginine. After 96 h of treatment motile parasites were observed
in proline (92%), glucose (73%) and glutamate (51%), but not in
arginine or PBS controls.
Finally, the only enzymes involved in arginine metabolism
found in the T. cruzi genome project are arginyl-tRNA synthetases
and a previously described arginine kinase.
Arginine transport is related to arginine metabolism
N-Phosphorylated guanidino compounds, commonly referred
to as phosphagens, play a critical role as an energy reserve because
of the high energy phosphate that can be transferred when the
renewal of ATP is needed. It has also been proposed that these
compounds function in spatial buffering of cellular energy
production sites. So, phosphagens act as reserves not only of
ATP but also of inorganic phosphate, which is mostly returned to
the medium by metabolic consumption of ATP [20]. Earlier
studies demonstrated that T. cruzi arginine transport system is
coupled to arginine metabolism, specifically to the arginine kinase-
mediated synthesis of phosphoarginine, a phosphagen molecule
with a critical role as energy reservoir [6,20,21]. Arginine kinase
expression in T. cruzi epimastigotes is precisely regulated by
extracellular conditions increasing its levels during the parasites
growth curve [22]. As demonstrated above free intracellular
arginine is only used by arginine kinase, in addition to protein
synthesis, to synthesize phosphoarginine from ATP. In conse-
quence, the increase in the arginine concentration produced by
TcAAP3 over-expression would produce a displacement in the
equilibrium of the reaction toward the formation of phosphoar-
ginine with the consequent decrease of the concentration of ATP.
Such a dramatic effect as the decrease in ATP probably has
compensatory mechanisms. In order to test if this regulatory
mechanism is associated to arginine transport, arginine kinase
expression was evaluated during the parasite growth curve, in
TcAAP3 epimastigotes and GFP controls. Figure 2 (image 2)
shows a graphical comparison, of arginine kinase expression,
between the parasites that have increased the arginine transport
activity (AAP3) and controls (GFP). Western Blot and densitom-
etry analysis demonstrated that arginine kinase expression is
significantly lower, up to 32% in day 6th, in the parasites that
arginine transport is exacerbated. A possible explanation of this
down-regulation of arginine kinase is the metabolic need to
counteract the displacement of equilibrium toward the formation
of phosphoarginine.
Arginine uptake affects the intracellular ATP levels when
glucose is depleted in the medium
In order to test if variations in arginine concentrations could
regulate the cell energy homeostasis throughout arginine kinase,
the intracellular ATP levels, and the glucose concentration in the
media were determined in TcAAP3 epimastigotes and controls
samples. If the higher intracellular arginine concentrations affect
the arginine kinase equilibrium, the glycolytic ATP synthesis
would be a critical step to maintain the cell energy balance.
Therefore, according to this model when the extracellular glucose
is scarce the ATP levels should decrease more in TcAAP3
epimastigotes. As expected, the measured intracellular ATP levels
remained constant between 3 and 4 mM during the first 6 days of
the logarithmic phase of growth, and glucose was gradually
consumed decreasing from 7 to 2.4 mM. However, in the
stationary phase of growth (day 12) when de glucose concentration
in the medium is low (,0.5 mM) the ATP levels fall dramatically
to 0.6 mM in TcAAP3 epimastigotes but remain constant in
controls (Figure 3, image 1). These results indicate that an increase
in arginine concentration caused by TcAAP3 over-expression
could produce pleiotropic effects on the metabolism of the parasite
generated by an imbalance of ATP concentration. Such decrease
of ATP concentration could be the cause of the observed lower
growth rates of TcAAP3 epimastigotes in the stationary phase.
Figure 3 (image 2) summarizes the proposed arginine transport
and metabolism regulation model. To test this model, experiments
were repeated by adding glucose (2 g.L21) to stationary phase
cultures. According to the model’s prediction, both, controls and
TcAAP3 epimastigotes recovered the intracellular ATP levels (4.8
Figure 2. Arginine metabolism in T. cruzi. 1) Bioinformatic prediction of arginine metabolism. Using the KEGG arginine and proline metabolic
pathways as a reference, genes coding for putative arginine metabolism enzymes in T. cruzi were searched using protein sequences from other
organisms as baits. All enzyme EC numbers are indicated into the boxes, routes marked with a red cross were not identified in T. cruzi. AST: arginine
N-succinyltransferase; ADC: arginine decarboxylase; APT: arginine-pyruvate transaminase; and AMO: arginine 2-monooxygenase. 2) Western blot
analysis of arginine kinase expression was performed along the parasite growth curve between days 1 and 12. GFP control parasites (GFP) and
TcAAP3 over-expressing parasites (AAP3) were compared by band densitometry (upper panel). Arrow indicates the position of the 40 kDa molecular
weight marker. 3) A comparative epimastigotes growth curve was calculated from control (GFP) and TcAAP3 (AAP3) parasite cultures during 21 days.
doi:10.1371/journal.pone.0032760.g002
Figure 3. Regulation of arginine metabolism and ATP levels by
TcAAP3. 1) Intracellular ATP concentrations were measured using a
bioluminescence method and samples from different days of the
parasite growth curve. Bars indicated as ‘‘12+glu’’ represent the ATP
levels of parasites samples from day 12, cultured overnight in the
presence of 2 g.L21 glucose. 2) A brief summary of the arginine
transport and metabolism regulation model at the stationary phase of
epimastigote growth was constructed from the results herein
presented.
doi:10.1371/journal.pone.0032760.g003
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and 4.0 mM, respectively) after the addition of glucose (Figure 3,
image 1, bars indicated as ‘‘12+glu’’).
Arginine and lysine transporters are located into the
flagellar pocket
The flagellar pocket is an invagination in the trypanosomatids
plasma membrane that constitutes a multiorganelle complex that
is involved in the exchange with the extracellular medium and the
cell polarity and division [23]. In a previous work we reported that
the lysine transporter TcAAP7 was localized mainly in an
unidentified membrane structure close to the kinetoplast that
could be the flagellar pocket, the cytostome or the contractile
vacuole [11]. To determine if TcAAP3 has a similar localization,
different plasmid constructions were made using the T. cruzi
expression vector pTREXL. TcAAP3 (mCherry::TcAAP3) was
co-expressed with TcBilbo1 (TcBilbo1::eGFP) or TcAAP7
(eGFP::TcAAP7) in T. cruzi epimastigotes. TcBilbo1 was used as
a marker of the flagellar pocket’s collar, corresponding to a
boundary in the flagellar pocket that demarcates a subdomain
structure [23,24]. After parasites transfection, TcAAP3 fluores-
cence was mainly localized in the flagellar pocket in a single focus
close to collar stained by TcBilbo1 (Figure 4). In addition,
TcAAP3 co-localized with the lysine transporter TcAAP7
suggesting that the TcAAAP family could be concentrated in a
unique region of interchange with the extracellular medium, the
flagellar pocket. An interesting observation was the failure in
obtaining stable transfectant parasites expressing TcAAP3 fused to
a fluorescence protein, suggesting that the fusion protein could act
as a dominant negative mutation. In addition, the low TcAAP3
over-expression levels achieved, as mentioned above, reinforce the
idea that the precise regulation of intracellular arginine levels is
critical for parasite survival. Another issue to highlight is the
validation of TcBilbo1 as a flagellar pocket protein, because it is
the first marker for this subcellular structure in T. cruzi.
T. cruzi amino acid transporters translocate their substrates
against a concentration gradient that can reach difference of about
two orders of magnitude between the mammalian host plasma and
the parasite cytosol. For example, arginine concentration reference
values of human plasma are between 13–64 mM in adults while T.
cruzi intracellular concentration is in the millimolar range. These
features suggest that amino acid transporters could be used as a
gateway for traditional anti-parasitic drugs by the addition of
suitable functional groups recognized by these permeases [25] or
by rational design of molecules that may alter the transport activity
and thus the parasite viability as occurs with TcAAP3.
Acknowledgments
We are indebted with Prof. Fabio Augusto di Girolamo and Dr. Guadalupe
Larralde (Pontificia Universidad Cato´lica Argentina, UCA) for glucose
determinations.
Author Contributions
Conceived and designed the experiments: MRM CAP. Performed the
experiments: MRM MS LAB MMC JM. Analyzed the data: MRM MS
CAP. Contributed reagents/materials/analysis tools: CAP. Wrote the
paper: CAP.
References
1. Barrett MP, Burchmore RJ, Stich A, Lazzari JO, Frasch AC, et al. (2003) The
trypanosomiases. Lancet 362: 1469–1480.
2. Young GB, Jack DL, Smith DW, Saier MH, Jr. (1999) The amino acid/
auxin:proton symport permease family. Biochim Biophys Acta 1415: 306–
322.
3. Bouvier LA, Silber AM, Galvao Lopes C, Canepa GE, Miranda MR, et al.
(2004) Post genomic analysis of permeases from the amino acid/auxin family in
protozoan parasites. Biochem Biophys Res Commun 321: 547–556.
4. BerrimanM, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, et al. (2005) The
genome of the African trypanosome Trypanosoma brucei. Science 309: 416–422.
5. Akerman M, Shaked-Mishan P, Mazareb S, Volpin H, Zilberstein D (2004)
Novel motifs in amino acid permease genes from Leishmania. Biochem Biophys
Res Commun 325: 353–366.
6. Pereira CA, Alonso GD, Paveto MC, Flawia MM, Torres HN (1999) L-arginine
uptake and L-phosphoarginine synthesis in Trypanosoma cruzi. J Eukaryot
Microbiol 46: 566–570.
Figure 4. Subcellular localization of TcAAP3. Parasites co-transfected with the pTREXL-mCherry::TcAAP3 and pTREXL-Bilbo1::eGFP (upper
panels) or pTREXL-eGFP::TcAAP7 (lower panels) were analyzed by fluorescence microscopy, 24 h post-transfection. Differential interference contrast
(DIC), DAPI, eGFP (Marker), mCherry (TcAAP3) and the merged image (Merge) are showed in the indicated columns. White bars in the left corner of
the merged images represent 5 mm.
doi:10.1371/journal.pone.0032760.g004
T. cruzi Arginine Transporter
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e32760
7. Carrillo C, Canepa GE, Giacometti A, Bouvier LA, Miranda MR, et al. (2010)
Trypanosoma cruzi amino acid transporter TcAAAP411 mediates arginine
uptake in yeasts. FEMS Microbiol Lett 306: 97–102.
8. Shaked-Mishan P, Suter-Grotemeyer M, Yoel-Almagor T, Holland N,
Zilberstein D, et al. (2006) A novel high-affinity arginine transporter from the
human parasitic protozoan Leishmania donovani. Mol Microbiol 60: 30–38.
9. Darlyuk I, Goldman A, Roberts SC, Ullman B, Rentsch D, et al. (2009) Arginine
homeostasis and transport in the human pathogen Leishmania donovani. J Biol
Chem 284: 19800–19807.
10. Pereira CA, Carrillo C, Miranda MR, Bouvier LA, Canepa GE (2008)
[Trypanosoma cruzi: transport of essential metabolites acquired from the host].
Medicina (B Aires) 68: 398–404.
11. Inbar E, Canepa GE, Carrillo C, Glaser F, Suter Grotemeyer M, et al. (2010)
Lysine transporters in human trypanosomatid pathogens. Amino Acids.
12. Christensen HN (1990) Role of amino acid transport and countertransport in
nutrition and metabolism. Physiol Rev 70: 43–77.
13. Closs EI, Albritton LM, Kim JW, Cunningham JM (1993) Identification of a low
affinity, high capacity transporter of cationic amino acids in mouse liver. J Biol
Chem 268: 7538–7544.
14. Kim JW, Closs EI, Albritton LM, Cunningham JM (1991) Transport of cationic
amino acids by the mouse ecotropic retrovirus receptor. Nature 352: 725–728.
15. Camargo EP (1964) Growth and Differentiation in Trypanosoma Cruzi. I.
Origin of Metacyclic Trypanosomes in Liquid Media. Rev Inst Med Trop Sao
Paulo 6: 93–100.
16. Zingales B, Andrade SG, Briones MR, Campbell DA, Chiari E, et al. (2009) A
new consensus for Trypanosoma cruzi intraspecific nomenclature: second
revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz 104:
1051–1054.
17. Vazquez MP, Levin MJ (1999) Functional analysis of the intergenic regions of
TcP2beta gene loci allowed the construction of an improved Trypanosoma cruzi
expression vector. Gene 239: 217–225.
18. Marchini FK, de Godoy LM, Rampazzo RC, Pavoni DP, Probst CM, et al.
(2011) Profiling the Trypanosoma cruzi phosphoproteome. PLoS One 6:
e25381.
19. Silber AM, Colli W, Ulrich H, Alves MJ, Pereira CA (2005) Amino acid
metabolic routes in Trypanosoma cruzi: possible therapeutic targets against
Chagas’ disease. Curr Drug Targets Infect Disord 5: 53–64.
20. Pereira CA, Alonso GD, Paveto MC, Iribarren A, Cabanas ML, et al. (2000)
Trypanosoma cruzi arginine kinase characterization and cloning. A novel
energetic pathway in protozoan parasites. J Biol Chem 275: 1495–1501.
21. Pereira CA, Alonso GD, Ivaldi S, Silber A, Alves MJ, et al. (2002) Arginine
metabolism in Trypanosoma cruzi is coupled to parasite stage and replication.
FEBS Lett 526: 111–114.
22. Alonso GD, Pereira CA, Remedi MS, Paveto MC, Cochella L, et al. (2001)
Arginine kinase of the flagellate protozoa Trypanosoma cruzi. Regulation of its
expression and catalytic activity. FEBS Lett 498: 22–25.
23. Field MC, Carrington M (2009) The trypanosome flagellar pocket. Nat Rev
Microbiol 7: 775–786.
24. Zhou Q , Gheiratmand L, Chen Y, Lim TK, Zhang J, et al. (2010) A
comparative proteomic analysis reveals a new bi-lobe protein required for bi-
lobe duplication and cell division in Trypanosoma brucei. PLoS One 5: e9660.
25. Chollet C, Baliani A, Wong PE, Barrett MP, Gilbert IH (2009) Targeted
delivery of compounds to Trypanosoma brucei using the melamine motif.
Bioorg Med Chem 17: 2512–2523.
T. cruzi Arginine Transporter
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e32760
